On August 31, 2022 Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, reported that Management will participate in the upcoming investor events set out below (Press release, Transgene, AUG 31, 2022, View Source [SID1234618834]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

– Pareto Securities, 13th Annual Healthcare Conference – Stockholm, Sweden
September 8, 2022

– Transgene’s R&D Day – Paris, France
September 27, 2022

– Investor Access Forum – Paris, France
October 6 & 7, 2022

– HealthTech Innovation Days 2022 – Paris, France
October 13 & 14, 2022

– EigenKapitalForum – Frankfurt (Main), Germany
November 28, 2022